Prostate volume may be saturation biopsy criterion
January 1st 2007Chicago-Saturation prostate biopsy (SPB) may offer an effective follow-up tool for diagnosing prostate cancer in men with a prior negative biopsy, persistently elevated PSA, and a prostate gland volume less than 37 cc, according to researchers from the Medical College of Georgia and Augusta Veterans Affairs Medical Center.
Search narrows for African-American prostate cancer gene
January 1st 2007Boston-Researchers at the Harvard Medical School, the Broad Institute, and the Dana-Farber Cancer Institute appear to be closing in on one or more of the genes that elevate the risk of prostate cancer in African-American men. They have narrowed the search to a 3.8 million nucleo-tide stretch DNA on the long arm of chromosome 8.
Combination BPH-OAB therapy controls symptoms
January 1st 2007New York-Men bothered by overactive bladder and prostate enlargement symptoms who are treated simultaneously with the anticholinergic drug tolterodine tartrate extended-release capsules (Detrol LA) and the alpha-blocker tamsulosin (Flomax) report better symptom control and quality of life than do men treated with either one of the medications or placebo, according to a recently published study (JAMA 2006; 296:2319-28).
Watchful waiting is possible option for renal masses
January 1st 2007Chicago-In patients with a contrast-enhancing renal mass, delayed intervention after watchful waiting does not adversely affect pathologic outcomes, results of a retrospective study designed to gain insight into the natural history of "incidentalomas" indicate. This holds true even for some lesions that are relatively large at diagnosis or found on follow-up to be rapidly growing, researchers from University of North Carolina at Chapel Hill reported at the American College of Surgeons clinical congress.
Congressional power shift: MDs will feel impact on many fronts
January 1st 2007Washington-The results of the November congressional elections, which caused a dramatic shift of power on Capitol Hill from Republicans to Democrats, will have significant implications for urologists and other physicians as they seek to build their practices and serve their patients in the years ahead.
Study suggests stopping prostate biopsies after four
January 1st 2007Chicago-Sextant biopsy with a transition zone or a laterally directed template loses efficacy in prostate cancer diagnosis with repeat testing, but only after four negative biopsies have been taken, researchers from Harvard Medical School reported at the American College of Surgeons clinical congress here.
Prostate inflammation not a predictor of cancer
January 1st 2007Chicago-Initial analyses from a retrospective study involving almost 600 men undergoing prostate needle biopsy show no association between inflammation on initial or subsequent biopsy and prostate cancer. However, the investigators from Harvard Medical School are withholding any conclusions while they continue their research.
Imaging technologies reshape prostate cancer treatment
January 1st 2007Chicago-Although open radical prostatectomy remains the gold standard of treatment for clinically localized prostate cancer, laparoscopic prostatectomy and, more recently, robot-assisted laparoscopic prostatectomy are rapidly increasing in popularity as alternatives to traditional open prostatectomy techniques.
ABU addresses concerns about cost, value of MOC
January 1st 2007Chicago-In 2000, the American Board of Medical Specialties assembly voted to commit member boards to Maintenance of Certification for their diplomates holding time-limited certificates. The American Board of Urology will introduce its MOC program in 2007, but during its development, the ABU has received a number of complaints and questions about MOC from urologists.
ABU plans maintenance of certification to be flexible, relevant
January 1st 2007Maintenance of Certification (MOC) has become a controversial topic among practicing urologists since the concept was first introduced by the American Board of Medical Specialties (ABMS) 8 years ago. As work on a final MOC plan for urologists continues, the American Board of Urology (ABU) says its plan will be flexible in format, relevant to clinical practice, and not overly burdensome. In this exclusive interview, current ABU President Linda D. Shortliffe, MD, outlines details of the program and how it will relate to actual practice.
New MRI software results in improved 3-D images
January 1st 2007Chicago-Volumetric three-dimensional magnetic resonance urography (MRU) is a new imaging modality that is already proving to be a valuable tool for enhancing the diagnosis of various urologic conditions in pediatric patients. In addition, with a potential for use in functional and dynamic imaging, it may ultimately take on a greater role and enable streamlining of the algorithm for diagnostic evaluation, said urologists from Children's Hospital of Los Angeles (CHLA) and the University of Southern California.
Adult male circumcision reduces risk of HIV
December 21st 2006A branch of the National Institutes of Health announced an early end to two clinical trials of adult male circumcision because an interim review of trial data revealed that medically performed circumcision significantly reduces a man's risk of acquiring HIV through heterosexual intercourse.
OAB drug reduces urgency episodes, increases warning time
December 21st 2006Patients with overactive bladder who are treated with solifenacin succinate (Vesicare) experience statistically significant reductions in episodes of urgency, suggests a study presented at the International Continence Society annual meeting in Christchurch, New Zealand.
Older men with prostate cancer benefit from early treatment
December 21st 2006Men between 65 and 80 years of age who receive treatment for early-stage, localized prostate cancer appear to live significantly longer than men who do not receive treatment, according to the authors of a retrospective study from the University of Pennsylvania School of Medicine, Philadelphia.
Decline in testosterone levels seen among American men
December 7th 2006A substantial, yet unrecognized age-dependent population-level decrease in testosterone in American men has been observed, potentially due to birth cohort differences or to health or environmental effects not captured in observed data, suggest researchers from the New England Research Institutes, Watertown, MA.